New Delhi: Pfizer will seek authorisation from the US for the third dose of its COVID-19 vaccine. It said on Thursday that another jab in a year’s time could boost ...
New Delhi: Clinical trials of the third booster dose of COVID-19 vaccine Covaxin started at All India Institute of Medical Sciences, Delhi, on Monday. The trial will be conducted on ...
New Delhi: An expert panel of Drugs Controller General of India (DCGI) has permitted Bharat Biotech to administer a third dose of its COVID-19 vaccine Covaxin to a select group ...